Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Novel ARF6 inhibitors with robust in vivo efficacy

July 1, 2016

HXP-124 as a novel antifungal agent for the treatment for onychomycosis

July 1, 2016

SER-262 prevents recurrence in patients with primary CDI

June 30, 2016

ACRAF patents DNA gyrase and DNA topoisomerase IV inhibitors

June 30, 2016

Ablynx to license FOX technology for study of inhaled anti-RSV nanobody

June 29, 2016

Cempra submits solithromycin MAA to EMA

June 29, 2016

FDA approves Epclusa as pan-genotypic single-tablet regimen for chronic HCV infection

June 29, 2016

Bacillus anthracis capsule conjugate vaccine protects rhesus macaques against inhalational anthrax

June 29, 2016

Hookipa Biotech initiates first-in-human study of HB-101 vaccine for CMV

June 29, 2016

Spero Therapeutics presents new MvfR inhibitor for P. aeruginosa infections

June 28, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...